Cargando…
Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine
Epilepsy is among the most common neurological chronic disorders, with a prevalence of 0.5–1%. Despite the introduction of new antiepileptic drugs during recent years, about one third of the epileptic population remain drug-resistant. Hence, especially in the pediatric population limited by differen...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164301/ https://www.ncbi.nlm.nih.gov/pubmed/35668937 http://dx.doi.org/10.3389/fphar.2022.832929 |